Developments in scalable strategies for detecting early markers of cognitive decline

R Whelan, FM Barbey, MR Cominetti, CM Gillan… - Translational …, 2022 - nature.com
Effective strategies for early detection of cognitive decline, if deployed on a large scale,
would have individual and societal benefits. However, current detection methods are …

Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework

E Matar, JM Shine, GM Halliday, SJG Lewis - Brain, 2020 - academic.oup.com
Fluctuating cognition is a complex and disabling symptom that is seen most frequently in the
context of Lewy body dementias encompassing dementia with Lewy bodies and Parkinson's …

Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event‐Related Potential

J Olichney, J Xia, KJ Church, HJ Moebius - Neural Plasticity, 2022 - Wiley Online Library
Neurodegenerative diseases, such as Alzheimer's disease (AD), and their associated
deterioration of cognitive function are common causes of disability. The slowly developing …

Severe cholinergic terminal loss in newly diagnosed dementia with Lewy bodies

N Okkels, J Horsager, M Labrador-Espinosa… - Brain, 2023 - academic.oup.com
Cholinergic changes play a fundamental role in the natural history of dementia with Lewy
bodies and Lewy body disease in general. Despite important achievements in the field of …

The clinical utility of the auditory P300 latency subcomponent event-related potential in preclinical diagnosis of patients with mild cognitive impairment and Alzheimer's …

AS Howe, A Bani-Fatemi, V De Luca - Brain and cognition, 2014 - Elsevier
The present meta-analysis investigated the clinical utility of the auditory P300 latency event-
related potential in differentiating patients with Alzheimer's disease (AD), patients with mild …

Electroencephalogram and Alzheimer's disease: clinical and research approaches

A Tsolaki, D Kazis, I Kompatsiaris… - International journal …, 2014 - Wiley Online Library
Alzheimer's disease (AD) is a neurodegenerative disorder that is characterized by cognitive
deficits, problems in activities of daily living, and behavioral disturbances …

P300 and neuropsychological assessment in mild cognitive impairment and Alzheimer dementia

MA Parra, LL Ascencio, HF Urquina, F Manes… - Frontiers in …, 2012 - frontiersin.org
Only a small proportion of individuals with Mild Cognitive Impairment (MCI) will convert to
dementia. Methods currently available to identify risk for conversion do not combine enough …

A meta-analysis of acupuncture use in the treatment of cognitive impairment after stroke

F Liu, ZM Li, YJ Jiang, LD Chen - The Journal of Alternative and …, 2014 - liebertpub.com
Objective: This meta-analysis was conducted to evaluate the efficacy of acupuncture on
cognitive impairment (function) after a stroke. Design: Randomized controlled trials (RCTs) …

Biomarkers in Alzheimer's disease with a special emphasis on event-related oscillatory responses

GG Yener, E Başar - Supplements to Clinical neurophysiology, 2013 - Elsevier
Alzheimer's disease (AD) is a devastating neurodegenerative dementing illness. Early
diagnosis at the prodromal stage is an important topic of current research. Significant …

Auditory event-related potentials in mild cognitive impairment and Alzheimer's disease

C Morrison, S Rabipour, F Knoefel… - Current Alzheimer …, 2018 - ingentaconnect.com
Background: Mild cognitive deficits are more likely to occur with increasing age, and become
more pronounced for people diagnosed with mild cognitive impairment (MCI) and …